These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2393300)

  • 1. Inhibition of cathepsin B and papain by peptidyl alpha-keto esters, alpha-keto amides, alpha-diketones, and alpha-keto acids.
    Hu LY; Abeles RH
    Arch Biochem Biophys; 1990 Sep; 281(2):271-4. PubMed ID: 2393300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
    Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
    J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Peptidyl-2-haloacetyl hydrazines as active site directed inhibitors of papain and cathepsin B.
    Giordano C; Calabretta R; Gallina C; Consalvi V; Scandurra R
    Farmaco; 1991 Dec; 46(12):1497-516. PubMed ID: 1821630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cathepsin B by peptidyl aldehydes and ketones: slow-binding behavior of a trifluoromethyl ketone.
    Smith RA; Copp LJ; Donnelly SL; Spencer RW; Krantz A
    Biochemistry; 1988 Aug; 27(17):6568-73. PubMed ID: 3219354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl O-acyl hydroxamates: potent new inactivators of cathepsin B.
    Smith RA; Coles PJ; Spencer RW; Copp LJ; Jones CS; Krantz A
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1201-6. PubMed ID: 3178802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent slow-binding inhibition of cathepsin B by its propeptide.
    Fox T; de Miguel E; Mort JS; Storer AC
    Biochemistry; 1992 Dec; 31(50):12571-6. PubMed ID: 1472493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
    Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
    J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Keto amide inhibitors of aminopeptidases.
    Ocain TD; Rich DH
    J Med Chem; 1992 Feb; 35(3):451-6. PubMed ID: 1738140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of human neutrophil elastase and cathepsin G by peptidyl 1,2-dicarbonyl derivatives.
    Mehdi S; Angelastro MR; Burkhart JP; Koehl JR; Peet NP; Bey P
    Biochem Biophys Res Commun; 1990 Jan; 166(2):595-600. PubMed ID: 2302225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific synthesis of peptidyl alpha-keto amides as inhibitors of calpain.
    Harbeson SL; Abelleira SM; Akiyama A; Barrett R; Carroll RM; Straub JA; Tkacz JN; Wu C; Musso GF
    J Med Chem; 1994 Sep; 37(18):2918-29. PubMed ID: 8071940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships for inhibition of papain by peptide Michael acceptors.
    Liu S; Hanzlik RP
    J Med Chem; 1992 Mar; 35(6):1067-75. PubMed ID: 1552501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity studies of fluoroketone inhibitors of alpha-lytic protease and human leukocyte elastase.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1990 Jul; 280(1):137-46. PubMed ID: 2353815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.
    Chan VJ; Selzer PM; McKerrow JH; Sakanari JA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
    Hall A; Dalbøge H; Grubb A; Abrahamson M
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and -161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Kinetic studies up to pH 8 of the hydrolysis of N-alpha-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide catalysed by cathepsin B and of L-arginine 2-naphthylamide catalysed by cathepsin H.
    Willenbrock F; Brocklehurst K
    Biochem J; 1985 Apr; 227(2):521-8. PubMed ID: 3890831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of cysteine proteases.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.
    Pliura DH; Bonaventura BJ; Smith RA; Coles PJ; Krantz A
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):759-62. PubMed ID: 1471990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray crystal structure of papain complexed with cathepsin B-specific covalent-type inhibitor: substrate specificity and inhibitory activity.
    Matsumoto K; Murata M; Sumiya S; Mizoue K; Kitamura K; Ishida T
    Biochim Biophys Acta; 1998 Mar; 1383(1):93-100. PubMed ID: 9546050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.